Skip to main content
Terug
Watch Compare

Medicale Corp.

Datakwaliteit: 83%
MCLE
OTC Services Health Services
€ 0,10
▼ € 0,05 (-33,33%)
Marktkapitalisatie: 592.000,0
Prijs
€ 0,10
Marktkapitalisatie
592.000,0
Dagbereik
—
52-Weeksbereik
—
Volume
—
Openen —
50D / 200D Gem.
—
50D / 200D Gem.
—

Quick Summary

Belangrijkste Punten

Negative free cash flow of -19.748,0

Groei

Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Kwaliteit

Return on Equity
N/A
ROICN/A
Net MarginN/A
Op. MarginN/A

Veiligheid

Debt / Equity
N/A
Current Ratio0,00
Interest Coverage-2,66

Waardering

PE (TTM)
-17,53
Onder sectorgemiddelde (-1,18)
P/B RatioN/A
EV/EBITDAN/A
Dividend YieldN/A

Koershistorie

Financiële Trends

Sectorvergelijking

vs Services sector mediaan (515 peers)
Metriek Aandeel Sector Mediaan
P/E -17,5 -1,2
P/B — 1,4
ROE % — -16,0
Net Margin % — -18,7
Rev Growth 5Y % — 4,0
D/E — 0,4

Koersdoel Analisten

Geen analistendekking beschikbaar

Winstschattingen

Geen toekomstige schattingen beschikbaar

All Fundamental Metrics
Growth
Revenue Growth (1Y) N/A Revenue Growth (3Y) N/A
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) N/A Net Income (TTM) -33.763,0
ROE N/A ROA N/A
Gross Margin N/A Operating Margin N/A
Net Margin N/A Free Cash Flow (TTM) -19.748,0
ROIC N/A FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 0,00
Interest Coverage -2,66 Asset Turnover N/A
Working Capital -32.202 Tangible Book Value -145.376
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -17,53 Forward P/E N/A
P/B Ratio N/A P/S Ratio N/A
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -3,34%
Market Cap 592.000,0 Enterprise Value 592.000,0
Per Share
EPS (Diluted TTM) -0,01 Revenue / Share N/A
FCF / Share 0,00 OCF / Share 0,00
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue N/A FCF Conversion 58,49%
SBC-Adj. FCF N/A Growth Momentum N/A

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue — — — 0,0 0,0
Net Income -41.153,0 -58.213,0 -37.138,0 -46.419,0 -32.152,0
EPS (Diluted) -0,01 -0,01 -0,01 -0,01 —
Gross Profit — — — — —
Operating Income -33.493,0 -54.707,0 -37.593,0 -46.419,0 -32.152,0
EBITDA — — — — —
R&D Expenses — — — — —
SG&A Expenses — — — — —
D&A — — — — —
Interest Expense 7.501,0 3.506,0 — — —
Income Tax 0,0 0,0 0,0 0,0 0,0

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 0,0 159,0 159,0 0,0 28.275,0
Total Liabilities 140.086,0 99.092,0 — — —
Shareholders' Equity -140.086,0 -98.933,0 -40.720,0 -54.774,0 -8.355,0
Total Debt — — — — —
Cash & Equivalents — — — — 18.475,0
Current Assets 0,0 159,0 159,0 0,0 18.675,0
Current Liabilities 33.652,0 15.507,0 40.879,0 54.774,0 36.630,0